Jason Shafrin's Blog Named to Top 100 Economics Blogs of 2017 List
For the second year in a row, Precision Health Economics Senior Research Economist Jason Shafrin’s blog, “Healthcare Economist,” has been named by Intelligent Economist to their list of Top 100 Economics Blogs (worldwide). Jason’s blog is listed first in the economic blogs category, with Intelligent Economist describing the content as “filled with unbiased and research-driven critiques of today’s healthcare issues like value-based purchasing, the health insurance market, and Medicare policy research, which sometimes is hard to find given the political divide in American healthcare.”
To read Jason’s blog, “Healthcare Economist,” please click here.
To see Intelligent Economist‘s complete list of 2017 top economics blogs, please click here.
By: Jason Shafrin, PhD Sr. Director, Policy and Economics and Jacki Chou, MPL Senior Director, Policy and Economics The recent announcement that CVS Caremark will use value-based metrics to inform formulary design at first appears a step in the right direction. However, using value measurements from a single nongovernmental organization—the Institute for Clinical and Economic Review (ICER)—based on a limited picture of treatment value may be problematic. Using this single assessment of value in an effort solely to exclude drugs from a major insurance formulary is even more worrisome and fails to recognize the heterogeneity in patient clinical needs and preferences.